Metabolic Research, Weight Management Research
$280.00 – $636.65Price range: $280.00 through $636.65
Retatrutide is an investigational triple agonist studied for its activity at the GIP, GLP-1, and glucagon receptors, with research focused on metabolic regulation, energy balance, glucose metabolism, and related physiological pathways.
Stock
Shipping
For research purposes only. Not intended for human consumption.
Product details
Essential details for your research.
Retatrutide is an investigational compound designed to interact with three metabolic hormone receptors: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon.
Its multi-receptor activity has made it a subject of scientific investigation into metabolic regulation, glucose homeostasis, energy balance, and body weight regulation. Research explores how these signaling pathways interact and their potential implications for metabolic science, including areas relevant to obesity and type 2 diabetes research.
Retatrutide remains under clinical investigation, and its pharmacological properties and potential applications continue to be evaluated in scientific studies.
This product is presented as a lyophilized powder in a vial.
We aim to make every order a smooth experience. Orders are processed within 24–72 business hours after payment confirmation. Shipping is available to eligible destinations within the United States, with a flat shipping fee of $13. Tracking details will be sent by email once your order ships.
For more information about shipping, returns, and our policies, please visit our Shipping Policy.
Research use only
Quick links
Explore
Support
Legal
Exclusively for research purposes.
All products offered by Premium Peptides are intended exclusively for research purposes and are not intended for human consumption. Research Use Only. Not for Human Consumption.
© 2026 Premium Peptides. All rights reserved.
Search peptides
Are you over 21 years of age?
You must be of legal age in accordance with the law of your province to access this website. By entering this site you agree to our Privacy Policy.